Transgenic CD8αβ co-receptor rescues endogenous TCR function in TCR-transgenic virus-specific T cells
Background Genetically engineered virus-specific T cells (VSTs) are a platform for adoptive cell therapy after allogeneic hematopoietic stem cell transplantation. However, redirection to a tumor-associated antigen by the introduction of a transgenic T-cell receptor (TCR) reduces anti-viral activity,...
Main Authors: | Malcolm K Brenner, Caroline Arber, Gagan Bajwa, Inès Lanz, Mara Cardenas |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-07-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/8/2/e001487.full |
Similar Items
-
Rapid Generation of TCR and CD8αβ Transgenic Virus Specific T Cells for Immunotherapy of Leukemia
by: Gagan Bajwa, et al.
Published: (2022-04-01) -
Erratum: Rapid generation of TCR and CD8αβ transgenic virus specific T cells for immunotherapy of leukemia
by: Frontiers Production Office
Published: (2023-03-01) -
Distinct Features of Canine Non-conventional CD4−CD8α− Double-Negative TCRαβ+ vs. TCRγδ+ T Cells
by: Friederike V. Rabiger, et al.
Published: (2019-11-01) -
The molecular signature underlying the thymic migration and maturation of TCRαβ+ CD4+ CD8 thymocytes.
by: Fei Teng, et al.
Published: (2011-01-01) -
Identification and Regulation of TCRαβ+CD8αα+ Intraepithelial Lymphocytes in Murine Oral Mucosa
by: Ruiqing Wu, et al.
Published: (2020-08-01)